HNGE
Hinge Health, Inc.
Price Chart
Latest Quote
$113.90
+2.19 (+1.96%)
Current Price
| Previous Close | $111.71 |
| Open | $111.60 |
| Day High | $114.41 |
| Day Low | $111.01 |
| Volume | 1,278,356 |
Stock Information
| Shares Outstanding | 62.47M |
| Total Debt | $5.88M |
| Cash Equivalents | $389.39M |
| Revenue | $720.06M |
| Net Income | $107.28M |
| Sector | Healthcare |
| Industry | Health Information Services |
| Market Cap | $9.19B |
| P/E Ratio | 37.59 |
| EPS (TTM) | $3.03 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $8.81B |
| Sales | $720.06M |
| Income | $107.28M |
| Book/sh | $4.29 |
| Cash/sh | $6.23 |
| Employees | 1K |
Financial Ratios
| Quick Ratio | 1.07 |
| Current Ratio | 1.34 |
| Debt/Eq | 1.71 |
Returns & Margins
| ROA | 7.70% |
| ROE | 30.38% |
| Gross Margin | 84.54% |
| Operating Margin | 19.00% |
| Profit Margin | 15.15% |
Ownership
| Insider Ownership | 4.75% |
| Institutional Ownership | 98.85% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 37.25 |
| P/S | 12.76 |
| P/B | 26.53 |
Analyst Data
| Recommendation | buy |
| Target Price | $114.31 |
Technical Indicators
| SMA20 | $103.90 |
| SMA50 | $96.48 |
| SMA200 | $66.02 |
| RSI | 74.95 |
| ATR | 4.5316 |
| Shares Float | 50.62M |
| Short Float | 10.27% |
| Short Ratio | 3.39 |
| Rel Volume | 0.67 |
Performance History
| Week | +5.94% |
| Month | +23.20% |
| Quarter | +53.79% |
| 6 Months | +154.58% |
| YTD | +150.00% |
| Year | +129.64% |
| 10 Years | +203.25% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $113.90 | 1,278,400 |
| 2026-10-26 | $111.71 | 2,075,900 |
| 2026-10-23 | $111.52 | 1,562,100 |
| 2026-10-22 | $109.93 | 2,264,000 |
| 2026-10-21 | $112.00 | 2,743,300 |
| 2026-10-20 | $107.51 | 4,093,700 |
| 2026-10-19 | $103.96 | 1,236,700 |
| 2026-10-16 | $99.16 | 1,758,400 |
| 2026-10-15 | $104.96 | 1,685,600 |
| 2026-10-14 | $105.00 | 1,624,500 |
| 2026-10-13 | $105.14 | 879,600 |
| 2026-10-12 | $104.82 | 1,343,900 |
| 2026-10-09 | $102.90 | 1,702,100 |
| 2026-10-08 | $98.00 | 912,300 |
| 2026-10-07 | $97.86 | 2,652,000 |
| 2026-10-06 | $98.35 | 2,907,900 |
| 2026-10-05 | $98.35 | 3,175,000 |
| 2026-10-02 | $97.67 | 975,300 |
| 2026-10-01 | $97.94 | 1,415,700 |
| 2026-09-30 | $97.24 | 1,634,800 |
| 2026-09-29 | $95.21 | 1,723,800 |
| 2026-09-28 | $92.45 | 1,276,600 |
About Hinge Health, Inc.
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.
đ° Latest News
No news articles available at the moment. Check back later for updates on HNGE.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | |||
| Reconciled Cost Of Revenue | $119,638,000 | $90,502,000 | $98,551,000 |
| Cost Of Revenue | $119,638,000 | $90,502,000 | $98,551,000 |
| Total Revenue | $587,860,000 | $390,404,000 | $292,730,000 |
| Operating Revenue | $587,860,000 | $390,404,000 | $292,730,000 |
| Expenses | |||
| Total Expenses | $1,134,231,000 | $422,314,000 | $423,244,000 |
| Other Income Expense | $19,108,000 | $20,654,000 | $21,968,000 |
| Other Non Operating Income Expenses | $19,108,000 | $20,654,000 | $21,968,000 |
| Operating Expense | $1,014,593,000 | $331,812,000 | $324,693,000 |
| Selling And Marketing Expense | $316,951,000 | $167,058,000 | $147,619,000 |
| General And Administrative Expense | $329,505,000 | $63,915,000 | $67,016,000 |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $-528,261,000 | $-11,933,000 | $-108,141,000 |
| Normalized Income | $-528,261,000 | $-11,933,000 | $-108,141,000 |
| Net Income From Continuing And Discontinued Operation | $-528,261,000 | $-11,933,000 | $-108,141,000 |
| Total Operating Income As Reported | $-546,371,000 | $-31,910,000 | $-130,514,000 |
| Net Income Common Stockholders | $-424,087,000 | $-11,933,000 | $-108,141,000 |
| Net Income | $-528,261,000 | $-11,933,000 | $-108,141,000 |
| Net Income Including Noncontrolling Interests | $-528,261,000 | $-11,933,000 | $-108,141,000 |
| Net Income Continuous Operations | $-528,261,000 | $-11,933,000 | $-108,141,000 |
| Pretax Income | $-527,263,000 | $-11,256,000 | $-108,546,000 |
| Operating Income | $-546,371,000 | $-31,910,000 | $-130,514,000 |
| Gross Profit | $468,222,000 | $299,902,000 | $194,179,000 |
| Per Share | |||
| Diluted EPS | $-7.77 | $-0.15 | $-1.58 |
| Basic EPS | $-7.77 | $-0.15 | $-1.58 |
| Other | |||
| Tax Effect Of Unusual Items | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-541,238,000 | $-25,960,000 | $-124,887,000 |
| Reconciled Depreciation | $5,133,000 | $5,950,000 | $5,627,000 |
| EBITDA (Bullshit earnings) | $-541,238,000 | $-25,960,000 | $-124,887,000 |
| EBIT | $-546,371,000 | $-31,910,000 | $-130,514,000 |
| Diluted Average Shares | $54,577,000 | $78,015,947 | $91,903,788 |
| Basic Average Shares | $54,577,000 | $78,015,947 | $68,538,418 |
| Diluted NI Availto Com Stockholders | $-424,087,000 | $-11,933,000 | $-108,141,000 |
| Otherunder Preferred Stock Dividend | $-104,174,000 | $0 | $0 |
| Tax Provision | $998,000 | $677,000 | $-405,000 |
| Research And Development | $368,137,000 | $100,839,000 | $110,058,000 |
| Selling General And Administration | $646,456,000 | $230,973,000 | $214,635,000 |
| Other Gand A | $329,505,000 | $63,915,000 | $67,016,000 |
Fetched: 2026-10-21
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Assets | |||
| Net Tangible Assets | $311,928,000 | $353,288,000 | $363,486,000 |
| Total Assets | $744,761,000 | $673,259,000 | $622,528,000 |
| Total Non Current Assets | $210,857,000 | $89,813,000 | $92,648,000 |
| Other Non Current Assets | $13,726,000 | $9,412,000 | $6,377,000 |
| Investmentin Financial Assets | $113,172,000 | $0 | - |
| Goodwill And Other Intangible Assets | $66,608,000 | $63,414,000 | $63,792,000 |
| Other Intangible Assets | $2,512,000 | $1,807,000 | $2,185,000 |
| Current Assets | $533,904,000 | $583,446,000 | $529,880,000 |
| Other Current Assets | $6,474,000 | $6,946,000 | $4,367,000 |
| Current Deferred Assets | $50,939,000 | $32,647,000 | $27,945,000 |
| Prepaid Assets | $30,932,000 | $23,913,000 | $14,356,000 |
| Inventory | $15,636,000 | $10,873,000 | $13,293,000 |
| Receivables | $66,061,000 | $42,495,000 | $46,563,000 |
| Receivables Adjustments Allowances | $-6,092,000 | $-6,470,000 | $-3,439,000 |
| Other Receivables | $21,116,000 | $11,307,000 | $20,250,000 |
| Accounts Receivable | $51,037,000 | $37,658,000 | $29,752,000 |
| Cash Cash Equivalents And Short Term Investments | $363,862,000 | $466,572,000 | $423,356,000 |
| Cash And Cash Equivalents | $207,995,000 | $300,785,000 | $234,952,000 |
| Cash Equivalents | $167,569,000 | $263,659,000 | $202,901,000 |
| Cash Financial | $40,426,000 | $37,126,000 | $32,051,000 |
| Allowance For Doubtful Accounts Receivable | - | $-6,470,000 | $-3,439,000 |
| Gross Accounts Receivable | - | $48,965,000 | $50,002,000 |
| Debt | |||
| Total Debt | $8,039,000 | $11,072,000 | $15,732,000 |
| Long Term Debt And Capital Lease Obligation | $3,816,000 | $7,258,000 | $11,095,000 |
| Current Debt And Capital Lease Obligation | $4,223,000 | $3,814,000 | $4,637,000 |
| Liabilities | |||
| Total Liabilities Net Minority Interest | $366,225,000 | $256,557,000 | $195,250,000 |
| Total Non Current Liabilities Net Minority Interest | $3,816,000 | $7,258,000 | $11,095,000 |
| Current Liabilities | $362,409,000 | $249,299,000 | $184,155,000 |
| Current Deferred Liabilities | $300,855,000 | $217,632,000 | $140,473,000 |
| Payables And Accrued Expenses | $45,869,000 | $23,689,000 | $32,676,000 |
| Payables | $6,168,000 | $2,120,000 | $8,198,000 |
| Total Tax Payable | $6,168,000 | $2,120,000 | $8,198,000 |
| Equity | |||
| Common Stock Equity | $178,662,000 | $-434,570,000 | $-423,994,000 |
| Preferred Stock Equity | $199,874,000 | $851,272,000 | $851,272,000 |
| Total Equity Gross Minority Interest | $378,536,000 | $416,702,000 | $427,278,000 |
| Stockholders Equity | $378,536,000 | $416,702,000 | $427,278,000 |
| Gains Losses Not Affecting Retained Earnings | $-20,000 | $68,000 | $60,000 |
| Other Equity Adjustments | $-20,000 | $68,000 | $60,000 |
| Retained Earnings | $-1,050,996,000 | $-522,735,000 | $-510,802,000 |
| Other | |||
| Ordinary Shares Number | $79,171,304 | $78,015,947 | $78,015,947 |
| Share Issued | $79,171,304 | $78,015,947 | $78,015,947 |
| Tangible Book Value | $112,054,000 | $-497,984,000 | $-487,786,000 |
| Invested Capital | $178,662,000 | $-434,570,000 | $-423,994,000 |
| Working Capital | $171,495,000 | $334,147,000 | $345,725,000 |
| Capital Lease Obligations | $8,039,000 | $11,072,000 | $15,732,000 |
| Total Capitalization | $378,536,000 | $416,702,000 | $427,278,000 |
| Additional Paid In Capital | $1,229,678,000 | $88,097,000 | $86,748,000 |
| Capital Stock | $199,874,000 | $851,272,000 | $851,272,000 |
| Common Stock | $0 | $0 | $0 |
| Preferred Stock | $199,874,000 | $851,272,000 | $851,272,000 |
| Long Term Capital Lease Obligation | $3,816,000 | $7,258,000 | $11,095,000 |
| Current Deferred Revenue | $300,855,000 | $217,632,000 | $140,473,000 |
| Current Capital Lease Obligation | $4,223,000 | $3,814,000 | $4,637,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $11,462,000 | $4,164,000 | $6,369,000 |
| Current Accrued Expenses | $39,701,000 | $21,569,000 | $24,478,000 |
| Investments And Advances | $113,172,000 | $0 | - |
| Available For Sale Securities | $113,172,000 | - | - |
| Goodwill | $64,096,000 | $61,607,000 | $61,607,000 |
| Net PPE | $17,351,000 | $16,987,000 | $22,479,000 |
| Accumulated Depreciation | $-19,780,000 | $-16,564,000 | $-11,772,000 |
| Gross PPE | $37,131,000 | $33,551,000 | $34,251,000 |
| Leases | $203,000 | $203,000 | $203,000 |
| Other Properties | $6,861,000 | $9,607,000 | $13,256,000 |
| Machinery Furniture Equipment | $30,067,000 | $23,741,000 | $20,792,000 |
| Properties | $0 | $0 | $0 |
| Finished Goods | $8,960,000 | $4,128,000 | $8,067,000 |
| Work In Process | $116,000 | $1,911,000 | $3,421,000 |
| Raw Materials | $6,560,000 | $4,834,000 | $1,805,000 |
| Other Short Term Investments | $155,867,000 | $165,787,000 | $188,404,000 |
Fetched: 2026-10-21
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $165,377,000 | $45,229,000 | $-68,524,000 |
| Operating Activities | |||
| Operating Cash Flow | $171,441,000 | $49,002,000 | $-63,909,000 |
| Cash Flow From Continuing Operating Activities | $171,441,000 | $49,002,000 | $-63,909,000 |
| Investing Activities | |||
| Capital Expenditure | $-6,064,000 | $-3,773,000 | $-4,615,000 |
| Investing Cash Flow | $-113,763,000 | $18,312,000 | $1,501,000 |
| Cash Flow From Continuing Investing Activities | $-113,763,000 | $18,312,000 | $1,501,000 |
| Capital Expenditure Reported | $-5,356,000 | $-2,734,000 | $-2,639,000 |
| Financing Activities | |||
| Repurchase Of Capital Stock | $-65,028,000 | $0 | $0 |
| Issuance Of Capital Stock | $255,675,000 | $0 | $0 |
| Financing Cash Flow | $-150,468,000 | $-2,202,000 | $-3,000,000 |
| Cash Flow From Continuing Financing Activities | $-150,468,000 | $-2,202,000 | $-3,000,000 |
| Net Other Financing Charges | $-355,578,000 | $-2,812,000 | $-3,492,000 |
| Net Common Stock Issuance | $190,647,000 | $0 | $0 |
| Common Stock Issuance | $255,675,000 | $0 | $0 |
| Other | |||
| Issuance Of Debt | $4,934,000 | $0 | $0 |
| End Cash Position | $209,796,000 | $302,586,000 | $237,474,000 |
| Beginning Cash Position | $302,586,000 | $237,474,000 | $302,882,000 |
| Changes In Cash | $-92,790,000 | $65,112,000 | $-65,408,000 |
| Proceeds From Stock Option Exercised | $9,529,000 | $610,000 | $492,000 |
| Common Stock Payments | $-65,028,000 | $0 | $0 |
| Net Issuance Payments Of Debt | $4,934,000 | $0 | $0 |
| Net Long Term Debt Issuance | $4,934,000 | $0 | $0 |
| Long Term Debt Issuance | $4,934,000 | $0 | $0 |
| Net Investment Purchase And Sale | $-103,699,000 | $22,085,000 | $6,116,000 |
| Sale Of Investment | $368,589,000 | $346,628,000 | $459,451,000 |
| Purchase Of Investment | $-472,288,000 | $-324,543,000 | $-453,335,000 |
| Net Business Purchase And Sale | $-4,000,000 | $0 | $0 |
| Purchase Of Business | $-4,000,000 | $0 | $0 |
| Net PPE Purchase And Sale | $-708,000 | $-1,039,000 | $-1,976,000 |
| Purchase Of PPE | $-708,000 | $-1,039,000 | $-1,976,000 |
| Change In Working Capital | $-2,014,000 | $13,502,000 | $9,410,000 |
| Change In Other Working Capital | $19,644,000 | $38,646,000 | $8,196,000 |
| Change In Other Current Liabilities | $-3,719,000 | $-4,659,000 | $-4,111,000 |
| Change In Other Current Assets | $-181,000 | $377,000 | $677,000 |
| Change In Payables And Accrued Expense | $29,407,000 | $-10,975,000 | $11,558,000 |
| Change In Prepaid Assets | $-15,775,000 | $-9,155,000 | $5,651,000 |
| Change In Inventory | $-4,763,000 | $608,000 | $10,565,000 |
| Change In Receivables | $-26,627,000 | $-1,340,000 | $-23,126,000 |
| Changes In Account Receivables | $-26,627,000 | $-1,340,000 | $-23,126,000 |
| Other Non Cash Items | $50,099,000 | $33,570,000 | $23,661,000 |
| Stock Based Compensation | $643,009,000 | $739,000 | $1,645,000 |
| Provisionand Write Offof Assets | $3,061,000 | $5,410,000 | $4,857,000 |
| Asset Impairment Charge | $0 | $1,812,000 | $10,264,000 |
| Amortization Of Securities | $361,000 | $537,000 | $-10,759,000 |
| Deferred Tax | $53,000 | $-585,000 | $-473,000 |
| Deferred Income Tax | $53,000 | $-585,000 | $-473,000 |
| Depreciation Amortization Depletion | $5,133,000 | $5,950,000 | $5,627,000 |
| Depreciation And Amortization | $5,133,000 | $5,950,000 | $5,627,000 |
| Net Income From Continuing Operations | $-528,261,000 | $-11,933,000 | $-108,141,000 |
| Amortization Cash Flow | - | $400,000 | $400,000 |
| Amortization Of Intangibles | - | $400,000 | $400,000 |
| Depreciation | - | $5,600,000 | $5,300,000 |
Fetched: 2026-10-21